The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 175.00
Bid: 177.80
Ask: 178.40
Change: -7.80 (-4.27%)
Spread: 0.60 (0.337%)
Open: 183.00
High: 183.80
Low: 175.00
Prev. Close: 182.80
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

23 Jan 2017 07:01

RNS Number : 8142U
Essentra plc
23 January 2017
 

ESSENTRA PLC

 

A leading global provider of essential components and solutions

POST-CLOSE TRADING UPDATE

 

Essentra plc ("Essentra" or "the Company") today announces the following post-close trading update in respect of its financial year ended 31 December 2016 ("FY 2016").

Trading update

Trading in both the Component Solutions and Filtration Products Strategic Business Units ("SBUs") has been broadly consistent with the Company's update of 21 November 2016.

However, the performance of the Health & Personal Care Packaging SBU has been more challenging than previously anticipated and, as a result of continuing operational issues, there has been a further significant decline in both revenue and profitability during the last two months of the year - nor is there currently an expectation of a near-term improvement as the Company moves into 2017. This SBU will be receiving specific short-term focus and remedial attention from Paul Forman, Chief Executive, and other senior management.

As a result, and while the detailed year-end close and audit is ongoing, the Board expects adjusted operating profit to be at, or modestly below, the bottom end of the Company's previously communicated guidance of £137 - 142m.

Paul Forman has recently commenced a strategic review of the Company, and an update will be provided at the time of Essentra's H1 2017 results on 28 July 2017.

Financial position

The Company's draft management accounts indicate net debt as at 31 December 2016 of approximately £380m (2015: £374m) at the closing exchange rates of US$1.24 / £ and €1.17 / £, better than expectations and partly driven by improvements in the Company's working capital position. This is again before detailed year-end close reviews and is unaudited.

Subject to completion of the detailed year-end testing of asset carrying values, it is anticipated that the FY 2016 results will reflect an impairment with respect to the Health & Personal Care Packaging SBU.

The Company confirms that it expects to complete the divestment of its Porous Technologies business during Q1 2017. As previously communicated, the net proceeds from the transaction are anticipated to be in the region of £185 - 190m (taking into account tax leakage and costs pertaining to the divestment / necessary re-organisation of the Company), which is expected to result in a significant exceptional gain on disposal in the financial year ending 31 December 2017. The proceeds from the disposal of the Porous Technologies business will be used to repay existing debt facilities.

Other information

Essentra will announce its FY 2016 results on 17 February 2017.

Conference call

A conference call to discuss today's announcement with investors and analysts will start at 07:45 (UK time), which can be accessed using the following details:

Dial in, using the following details:

Dial-in number:

+44 (0)20 3427 1904 (UK / international participants)

+1 646 254 3360 (US participants)

Toll-free number:

0800 279 4977 (UK participants)

+1 877 280 2342 (US participants)

PIN code:

8913687

A replay of the call will additionally be available as follows:

Replay number:

+44 (0)20 3427 0598 (UK / international participants)

+1 347 366 9565 (US participants)

Toll-free number:

0800 358 7735 (UK participants)

+1 866 932 5017 (US participants)

Replay access code:

8913687

Replay available:

For 7 days

Market Abuse Regulation Statement

This announcement contains inside information.

Enquiries

Essentra plc

Joanna Speed, Corporate Affairs Director

Tel: +44 (0)1908 359100

Ogilvy PR London

James Stewart

Tel: +44 (0)7342 068609

E-mail: james.stewart@ogilvy.com

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions. Essentra focuses on the light manufacture and distribution of high volume, enabling components which serve customers in a wide variety of end-markets and geographies.

Component Solutions

The Components business is a global market leading manufacturer and distributor of plastic injection moulded, vinyl dip moulded and metal items. Operating units in 29 countries serve a very broad industrial base of customers with a rapid supply of products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics and construction.

The Pipe Protection Technologies business specialises in the manufacture of high performance innovative products from commodity resins to engineering-grade thermoplastics and polymer alloys for use in a range of end-markets. Locations in four countries, combined with a wide distributor network, serve customers around the world.

Essentra Extrusion is a leading custom profile extruder located in the Netherlands which offers a complete design and production service. One of the first companies to extrude plastics in 1956, Essentra is now one of Europe's most advanced suppliers of co-extrusion and tri-extrusion to all branches of industry.

The Security business has access to a wide portfolio of products and services, including printers, software and consumables from leading manufacturers.

Health & Personal Care Packaging

A leading global provider of packaging and authentication solutions to a diversified blue-chip customer base in the pharmaceutical, health & personal care, consumer and specialist packaging sectors. The business focuses on delivering value-adding innovation, quality and service through the provision of a wide range of printed products and solutions, including cartons, tapes, leaflets, foils, labels and authentication solutions.

The Speciality Tapes business has expertise in coating multiple adhesive systems in numerous technologies. With close to 3,000 adhesive products available for same-day shipping, Essentra's products can meet all high performance needs, from foam, magnetic, finger lift and acrylic high bond tapes to hook and loop and non-skid foam.

Filtration Products

Essentra Filter Products is the only global independent cigarette filter supplier. The nine worldwide locations, including a dedicated Technology Centre supported by three regional development facilities, provide a flexible infrastructure strategically positioned to serve the tobacco industry. The business supplies a wide range of value-adding high quality innovative filters, packaging solutions to the roll your own segment and analytical laboratory services for ingredient measurement to the industry.

Essentra Porous Technologies is a leading developer and manufacturer of custom fluid handling components, engineered from a portfolio of technologies that includes bonded and non-woven fibre, polyurethane foam and porous plastics. Representing innovations used in healthcare, consumer and industrial applications, its enabling components are found in a wide range of products from medical diagnostics tests to advanced wound care pads, inkjet printer cartridges, writing instruments, clean room wipes and air fresheners.

Headquartered in the United Kingdom, Essentra's global network extends to 33 countries and includes c. 9,000 employees, 53 principal manufacturing facilities, 64 sales & distribution operations and 5 research & development centres. For further information, please visit www.essentraplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAXFDAEEXEEF
Date   Source Headline
1st Apr 20213:54 pmRNSDirector/PDMR Shareholding
1st Apr 202110:10 amRNSTotal Voting Rights
30th Mar 20212:53 pmRNSDirector/PDMR Shareholding
30th Mar 202112:24 pmRNSDirector/PDMR Shareholding
10th Mar 20213:52 pmRNSDirector/PDMR Shareholding
5th Mar 20217:05 amRNSBoard Changes
5th Mar 20217:00 amRNSResults for the Full Year Ended 31 December 2020
2nd Mar 202111:41 amRNSHolding(s) in Company
1st Mar 20218:30 amRNSTotal Voting Rights
26th Feb 202112:00 pmRNSInvitation to Full Year 2020 Results Presentation
24th Feb 20214:03 pmRNSHolding(s) in Company
2nd Feb 20211:00 pmRNSDate for FY 2020 Results Announcement
1st Feb 20218:53 amRNSTotal Voting Rights
27th Jan 20217:12 amRNSDirector Declaration
8th Jan 20217:00 amRNSFY20 Pre-Close Trading Statement
4th Jan 20217:00 amRNSTotal Voting Rights
24th Dec 20207:00 amRNSHolding(s) in Company
4th Dec 202011:58 amRNSDirector Declaration
1st Dec 20208:11 amRNSTotal Voting Rights
27th Nov 20204:40 pmRNSSecond Price Monitoring Extn
27th Nov 20204:35 pmRNSPrice Monitoring Extension
16th Nov 202011:42 amRNSHolding(s) in Company
2nd Nov 202011:08 amRNSTotal Voting Rights
29th Oct 20204:41 pmRNSDirector/PDMR Shareholding
29th Oct 20204:37 pmRNSDirector/PDMR Shareholding
23rd Oct 20207:00 amRNSQ3 2020 Trading Update
14th Oct 202010:26 amRNSDirector/PDMR Shareholding
7th Oct 20207:00 amRNSHolding(s) in Company
1st Oct 20207:00 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSDirector/PDMR Shareholding
25th Sep 20209:59 amRNSDirector/PDMR Shareholding
24th Sep 20204:40 pmRNSHolding(s) in Company
24th Sep 202011:21 amRNSDirector/PDMR Shareholding
23rd Sep 20201:43 pmRNSHolding(s) in Company
18th Sep 202011:31 amRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSResults of Fundraise and Total Voting Rights
17th Sep 20204:40 pmRNSRetail Offer via PrimaryBid.com
17th Sep 20204:37 pmRNSIssue of Equity
17th Sep 20204:36 pmRNSAcquisition of 3C! Packaging, Inc.
10th Sep 20209:52 amRNSTotal Voting Rights
28th Aug 20207:03 amRNSAnnouncement of New Environmental KPIs and Targets
28th Aug 20207:00 amRNSResults For The Half Year Ended 30 June 2020
27th Aug 20207:00 amRNSChange of Corporate Broker
18th Aug 202012:00 pmRNSNotice of Results
10th Aug 20208:49 amRNSTotal Voting Rights
21st Jul 20207:00 amRNSHolding(s) in Company
17th Jul 20207:00 amRNSSettlement with US Department of Justice
3rd Jul 20207:00 amRNSHY 2020 Pre-Close Trading Statement
1st Jul 20202:01 pmRNSTotal Voting Rights
19th Jun 20203:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.